A phase II study of ECX in patients with carcinoma of unknown primary (CUP): Prospective evaluation of molecular classifiers.
H. S. Wasan
No relevant relationships to disclose
T. R. J. Evans
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Other Remuneration - Roche
M. Nicolson
No relevant relationships to disclose
D. Bowtell
No relevant relationships to disclose
K. Oien
Consultant or Advisory Role - bioTheranostics (U)
M. G. Erlander
Employment or Leadership Position - bioTheranostics
J. Paul
No relevant relationships to disclose
M. Maclean
No relevant relationships to disclose
L. McMahon
No relevant relationships to disclose